MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,847 | -30.8% | 1,175 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $27,236 | -0.2% | 1,175 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $27,295 | +60.1% | 1,175 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,049 | -22.5% | 1,175 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | -61.4% | 1,175 | -63.2% | 0.00% | -50.0% |
| Q2 2022 | $57,000 | – | 3,190 | +11714.8% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 27 | -38.6% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -75.0% | 44 | -64.5% | 0.00% | -100.0% |
| Q3 2014 | $4,000 | 0.0% | 124 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $4,000 | -33.3% | 124 | -41.5% | 0.00% | -75.0% |
| Q4 2012 | $6,000 | 0.0% | 212 | 0.0% | 0.00% | -20.0% |
| Q3 2012 | $6,000 | – | 212 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |